Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07134920 · ClinicalTrials.gov registry record
Norethindrone Impact on Receptiva Outcomes
A clinical trial of Infertility, Female and Infertility (IVF Patients), sponsored by Inception Fertility Research Institute.
- Active
- Registry status
- 700
- Enrollment target
- 1
- Study location
NCT07134920: Active study of Infertility, Female and Infertility (IVF Patients), sponsored by Inception Fertility Research Institute.
NCT07134920 is a study of Infertility, Female and Infertility (IVF Patients) that is active but no longer recruiting, run by Inception Fertility Research Institute. The registered enrollment target is 700 participants, above the 344-participant average among 18 other Infertility, Female trials with a reported enrollment target (103% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07134920, a study of Infertility, Female and Infertility (IVF Patients), is active but no longer recruiting, sponsored by Inception Fertility Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
This retrospective study aims to evaluate pregnancy outcomes in patients with a positive BCL6 test (ReceptivaDx, who were treated with either norethindrone acetate or Depo Lupron prior to embryo transfer. The current standard of care involves treatment with Depo Lupron, a GnRH agonist associated with significant hypoestrogenic side effects that mimic menopausal symptoms. Additionally, Depo Lupron is costly, with a retail price exceeding $2,000 per dose. In contrast, norethindrone acetate is a well-tolerated oral progestin, available at a fraction of the cost (under $100 for a one-month course). While prior studies have demonstrated comparable efficacy between Depo Lupron and norethindrone for managing endometriosis-associated pain, their relative effectiveness in improving reproductive outcomes-particularly in BCL6-positive patients undergoing embryo transfer-remains underexplored. This study seeks to address that gap by comparing ongoing pregnancy, live birth, and miscarriage rates between the two treatment groups. Hypothesis: IVF Patients testing positive for BCL6 and treated with norethindrone will not do worse than the current recommended treatment of 60 days Depo leuprolide as defined by two endpoint metrics, pregnancy rate and live birth rate.
Primary Outcome
To compare ongoing pregnancy rates in BCL6-positive patients treated with norethindrone acetate versus Depo Lupron acetate
Conditions Studied
Study Locations (1)
Pennsylvania
- Main Line Fertility - Bryn Mawr
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2025-08-12 |
| Est. Completion | 2026-07 |
What the registry record for NCT07134920 still lists
NCT07134920 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, above the 344-participant average among 18 other Infertility, Female trials with a reported enrollment target (103% higher).
The record links to 2 conditions, with Infertility, Female appearing as the primary indexed condition, and to 0 interventions.
NCT07134920 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07134920 about?
NCT07134920 is a clinical study titled "Norethindrone Impact on Receptiva Outcomes". This retrospective study aims to evaluate pregnancy outcomes in patients with a positive BCL6 test (ReceptivaDx, who were treated with either norethindrone acetate or Depo Lupron prior to embryo transfer. The current standard of care involves treatment with Depo Lupron, a GnRH agonist associated wit...
What is the current status of trial NCT07134920?
This trial is currently active not recruiting. The enrollment target is 700 participants. The study started on 2025-08-12. Estimated completion is 2026-07.
What conditions does trial NCT07134920 study?
This clinical trial studies the following conditions: Infertility, Female, Infertility (IVF Patients).
Who is sponsoring clinical trial NCT07134920?
This trial is sponsored by Inception Fertility Research Institute, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07134920 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility, Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07134920's enrollment target sits among peer trials
700 3rd of 18 higher than 16 of 18 other Infertility, Female trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility, Female trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial
RECRUITING · NA
-
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
RECRUITING · NA
-
Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation
RECRUITING · Phase 4
-
PROspective Study of Mothers' and Infants' Social and Epidemiologic Determinants of Health
RECRUITING
-
Ovarian Tissue Cryopreservation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI